
ElevenLabs doubles its valuation to $22bn in a $300m employee tender led by Wellington and T. Rowe Price
ElevenLabs has completed a $300m (about £224m) secondary share sale at a $22bn valuation, double the $11bn price set in its $500m Series D in February. Wellington and T. Rowe Price co-led the tender, which brought six new institutions onto the cap table.







